The announcement by NYU Langone’s Board of Trustees was praised by Kenneth Langone, board chair and co-chair of the search ...

More than 100 students at the Renaissance School of Medicine found out on Friday which hospital they'd be assigned to.

KIMMELMAN, M.D., PHD, as its next chief executive officer and dean of NYU Grossman School of Medicine. Kimmelman, a distinguished physician and internationally renowned researcher, most recently ...

New York City based NYU Langone Health has selected Alec Kimmelman, MD, PhD, as the next CEO and dean of NYU Grossman School of Medicine, effective Sept. 1. Dr. Kimmelman, a researcher and radiation ...

NYU Langone is now in talks about siting "a major hospital" at the Canon USA Inc. headquarters in Melville, the health system ...

A study led by scientists at NYU Langone Health sheds light on how the major cancer gene BRCA2 determines which cancer cells can be killed by a class of precision cancer drugs called PARP inhibitors.

Fourth-year medical students at the NYU Grossman School of Medicine found out Friday which residency programs were matched with. Donald Trump Announces Major Student Loan Change Study shows how ...

Mutations in BRCA2 — a gene known to repair damaged DNA and suppress tumor formation — can predict an individuals' predisposition to develop breast cancer, ovarian, prostate, pancreatic, and other ...

The American Academy of Dermatology has announced the results of its annual election. The Academy’s new officers and board members will lead the world’s largest dermatologic society, representing more ...

The AI Small Molecule Drug Discovery Center will focus on three core areas: designing novel drug-like molecules using generative AI, optimizing existing compounds to enhance their efficacy and safety, ...